Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Identify where to find high risk investments that offer potential for high returns. Explore various avenues to enhance your portfolio.
27,969 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
As tech markets evolve into 2026, two giants dominate discussions about broad exposure and concentration. This articl...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Keystone reveals a sizable new stake in the IDEF defense ETF, signaling growing investor interest in defense and indu...
Thursday brought a notable move for AMD as shares jumped on favorable analyst commentary and a rising server CPU TAM ...
Bitcoin has rebounded about 10% from a multi-year trough, but three on-chain signals must align before a sustained ra...
Tension in the Middle East threatens to throttle energy flows, with oil and gas markets reacting as investors reasses...
Palantir stock has captured attention as market conditions shift and AI headlines rise. This guide breaks down what’s...
SpaceX may be the headline grabber, but buying on day one isn’t a slam-dunk. This guide gives you three essential que...
When choosing biotech ETFs, investors face a trade-off between concentration and breadth. This article compares FBT a...
Volatile markets push cautious traders toward targeted bets. This piece highlights three ETFs that blend risk control...
Two oil-sector players, Occidental Petroleum and Energy Transfer, duke it out for the spot in a diversified portfolio...